Hepatitis C virus infection in HIV-infected patients

Mark S Sulkowski1

  • 1Division of Infectious Diseases, Johns Hopkins Medical Institutions, 1830 East Monument Street, Room 319, Baltimore, MD 21287, USA. msulkows@jhmi.edu

Current HIV/AIDS Reports
|August 11, 2005
PubMed

Insights

Hepatitis C (HCV) and HIV coinfection is common, with HCV-related liver disease causing significant illness in HIV patients. Treatment with pegylated interferon-alpha plus ribavirin is safe and effective for these individuals.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection affects 15-30% of HIV-infected individuals in the US due to shared transmission routes.
  • HCV-related liver disease is a leading cause of morbidity and mortality in HIV-coinfected patients, particularly with effective antiretroviral therapy (ART).

Purpose of the Study:

  • To review the epidemiology, natural history, and management of HCV in patients coinfected with HIV.
  • To highlight the complexities and recent advancements in treating HCV in this population.

Main Methods:

  • Review of recent randomized controlled trials and guidelines from the Infectious Diseases Society of America and the American Association for the Study of Liver Disease.
  • Focus on evidence regarding the safety, tolerability, and efficacy of HCV treatment in HIV-infected individuals.

Main Results:

  • Pegylated interferon-alpha plus ribavirin has demonstrated safety, tolerability, and efficacy in treating HCV in HIV-infected individuals.
  • Despite comorbidities and ART challenges, HCV treatment is recommended and feasible.

Conclusions:

  • HCV management in HIV-coinfected patients requires careful consideration of comorbidities and ART.
  • Effective HCV treatment options are now available, improving outcomes for coinfected individuals.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...